Reaching People, Changing Lives

At Aurinia Pharmaceuticals, we’re developing and delivering innovative products to patients suffering from debilitating diseases such as lupus nephritis (LN).

How We’re Helping Patients

Latest News

June 22, 2017 • 12:00am EDT

Aurinia Announces Results of Annual General Meeting

Read Press Release View All News

June 21, 2017 • 12:00am EDT

Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC

Read Press Release View All News

June 16, 2017 • 12:00am EDT

Voclosporin Remission Data from the Phase IIb AURA-LV Study Highlighted at EULAR 2017

Read Press Release View All News

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Today